Search research articles
Contact Us
Filters
Showing results (521-530 of 754) with videos related to
Page
of 76
Sort By:
The New England Journal of Medicine
|
October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
F M Sacks, M A Pfeffer, L A Moye, et al.
International Journal of Cardiology
|
February 2, 2024
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
Circulation. Heart Failure
|
May 24, 2011
Dyssynchrony, contractile function, and response to cardiac resynchronization therapy
Dorit Knappe, Anne-Catherine Pouleur, Amil M Shah, et al.
JACC. Heart Failure
|
April 12, 2014
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction)
Eldrin F Lewis, Yanhong Li, Marc A Pfeffer, et al.
American Heart Journal
|
February 23, 2020
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib
Jean-Claude Tardif, Marie-Pierre Dubé, Marc A Pfeffer, et al.
European Heart Journal
|
June 7, 2006
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
John J V McMurray, Fredrik L Andersson, Simon Stewart, et al.
Journal of the American College of Cardiology
|
November 13, 2007
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program
Akshay S Desai, Karl Swedberg, John J V McMurray, et al.
Circulation
|
November 21, 2007
Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease
Scott D Solomon, Julie Lin, Caren G Solomon, et al.
Circulation. Heart Failure
|
January 26, 2018
Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations
Peter van der Meer, Niels Grote Beverborg, Marc A Pfeffer, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 1, 2025
Long-term outcomes of recurrent myocardial infarction: a nationwide Danish study
Daniel Mølager Christensen, Deewa Zahir, Caroline Hartwell Garred, et al.
Page
of 76
Search research articles
Search
Showing results (521-530 of 754) with videos related to
Sort By:
Page
of 76
The New England Journal of Medicine
|
October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
F M Sacks, M A Pfeffer, L A Moye, et al.
International Journal of Cardiology
|
February 2, 2024
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
Circulation. Heart Failure
|
May 24, 2011
Dyssynchrony, contractile function, and response to cardiac resynchronization therapy
Dorit Knappe, Anne-Catherine Pouleur, Amil M Shah, et al.
JACC. Heart Failure
|
April 12, 2014
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction)
Eldrin F Lewis, Yanhong Li, Marc A Pfeffer, et al.
American Heart Journal
|
February 23, 2020
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib
Jean-Claude Tardif, Marie-Pierre Dubé, Marc A Pfeffer, et al.
European Heart Journal
|
June 7, 2006
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
John J V McMurray, Fredrik L Andersson, Simon Stewart, et al.
Journal of the American College of Cardiology
|
November 13, 2007
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program
Akshay S Desai, Karl Swedberg, John J V McMurray, et al.
Circulation
|
November 21, 2007
Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease
Scott D Solomon, Julie Lin, Caren G Solomon, et al.
Circulation. Heart Failure
|
January 26, 2018
Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations
Peter van der Meer, Niels Grote Beverborg, Marc A Pfeffer, et al.
European Heart Journal. Acute Cardiovascular Care
|
August 1, 2025
Long-term outcomes of recurrent myocardial infarction: a nationwide Danish study
Daniel Mølager Christensen, Deewa Zahir, Caroline Hartwell Garred, et al.
Page
of 76